Target intelligence / Profile preview

Ribosomal protein L21 pseudogene 117 (RPL21P117)

Target
RPL21P117
Molecular classification
Other (processed pseudogene)
01

Overview

Ribosomal protein L21 pseudogene 117 (RPL21P117) is a processed pseudogene related to the ribosomal protein L21 (RPL21) gene. Pseudogenes are segments of DNA that resemble functional genes but do not encode functional proteins due to mutations or truncations. RPL21P117 is not a protein-coding gene and does not have any documented molecular function, biological pathway association, or role as a therapeutic target. There are multiple RPL21 pseudogenes dispersed throughout the genome, and they are not considered functionally relevant for ribosomal activity or as drug targets[4][5]. This entry is not a functional protein or receptor and therefore is not considered a therapeutic target in pharmacology or molecular medicine. The actual therapeutically relevant gene/protein is Ribosomal protein L21 (RPL21), not its pseudogenes. RPL21 itself is a structural component of the 60S ribosomal subunit and is associated with diseases such as hypotrichosis simplex when mutated[4][5]. Aliases given (RPL21_53_1439, RPL21P117) reflect alternative ways of cataloging this pseudogene but do not correspond to a functional entity. RPL21P117 is a pseudogene, not a therapeutic target, and does not participate in known biological functions, disease pathogenesis, or drug pathways[4][5]. If the intended query was for the functional ribosomal protein, refer instead to "Ribosomal protein L21 (RPL21)"[4][5].

Other names
RPL21_53_1439RPL21P117

Beyond the preview

Go deeper on Ribosomal protein L21 pseudogene 117 (RPL21P117).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L21 pseudogene 117 (RPL21P117).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call